Skip to main content

Table 2 Agreement between mNGS and CMT

From: Application of metagenomic next-generation sequencing in the clinical diagnosis of infectious diseases after allo-HSCT: a single-center analysis

 

mNGS-positive

mNGS-negative

Total

Kappa, agreement

CMT-positive

17

1

18

0.059, 40.74%

CMT-negative

31

5

36

 

Total

48

6

54

 
  1. mNGS Metagenomic next-generation sequencing, CMT Conventional microbiological test
Back to article page

BMC Infectious Diseases

ISSN: 1471-2334

Contact us